Although our study focused on the effects of HDAC inhibitors on DNA replication, we also identified additional targets and pathways, including survivin and c-Myc, that support tumorigenesis in Ewing sarcoma tumors and are regulated by HDAC inhibitors. The gene discussed is BIRC5; the disease is Ewing sarcoma.